Startups

Director, Global Program Lead, External Innovation & Due Diligence

Acadia Pharmaceuticals · Princeton, New Jersey, United States; San Diego, California, United States; South San Francisco, California, United... · On-site

← All jobs
About Acadia Pharmaceuticals

Acadia advances care for underserved neurological disorders and rare diseases. Since our founding, we have been working at the forefront of healthcare to bring vital solutions to people who need them most. Backed by NEA.

About the role

The Director, External Innovation will serve as the R&D project/program lead for external opportunity due diligence, with a particular focus on clinical-stage assets and drug development programs. The role will lead cross-functional clinical, scientific, and strategic evaluation of opportunities aligned with Acadia’s corporate strategy and R&D portfolio across neuroscience, psychiatry, neuro-rare, and rare disease.

What they're looking for

  • Bachelor’s degree in a relevant scientific discipline required, advanced degree (PhD, PharmD, MD, or Master’s) preferred
  • 10-12 years of industry experience in the pharma or biotech industry
  • Experience in global R&D program management (clinical-stage assets), portfolio strategy or project leadership is required
  • Experience with clinical-stage assets is required
  • Experience leading cross-functional asset evaluations, scientific due diligence, portfolio assessments, and/or drug development strategy initiatives
  • Strong scientific expertise with the ability to evaluate complex clinical and preclinical data
More about this role

About Acadia Pharmaceuticals

Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference.

Please note that this position can be based in San Diego, CA, San Francisco, CA OR Princeton, NJ. Acadia's hybrid model requires this role to work in our office three days per week on average.

The Director, External Innovation will serve as the R&D project/program lead for external opportunity due diligence, with a particular focus on clinical-stage assets and drug development programs. The role will lead cross-functional clinical, scientific, and strategic evaluation of opportunities aligned with Acadia’s corporate strategy...

Read the full posting on Acadia Pharmaceuticals's site ↗

External Innovation

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.